imiquimod has been researched along with Hepatitis C in 5 studies
*Hepatitis C: INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horscroft, N; Laxton, C; Myangar, N; Parkinson, T; Rodman, J; Thomas, A | 1 |
| Ahsan, MJ; Balaraju, T; Ganta, NM; Gedda, G; Jadav, SS; Rathnakar, B; Satyanarayana, M; Yamajala, B | 1 |
| Deng, XZ; Ding, WL; Feng, L; Tang, SD; Wang, JJ; Xue, XX; Yue, M; Zhang, Y | 1 |
| Boehm, T; Klade, CS; Manns, MP; Schuller, E; von Gabain, A | 1 |
| Hirota, K; Ichii, S; Isobe, Y; Kawakami, H; Kurimoto, A; Ogino, T; Ogita, H; Sajiki, H; Takaku, H; Tobe, M | 1 |
1 review(s) available for imiquimod and Hepatitis C
| Article | Year |
|---|---|
A review on HCV inhibitors: Significance of non-structural polyproteins.
Topics: Antiviral Agents; Hepacivirus; Hepatitis C; Humans; Polyproteins; Structure-Activity Relationship; Viral Nonstructural Proteins | 2019 |
4 other study(ies) available for imiquimod and Hepatitis C
| Article | Year |
|---|---|
Investigating Toll-like receptor agonists for potential to treat hepatitis C virus infection.
Topics: Antiviral Agents; Cell Line, Tumor; Cytokines; Hepacivirus; Hepatitis C; Humans; Leukocytes, Mononuclear; Toll-Like Receptor 3; Toll-Like Receptor 7; Toll-Like Receptor 9; Toll-Like Receptors | 2007 |
Sex-specific association between X-linked Toll-like receptor 7 with the outcomes of hepatitis C virus infection.
Topics: Aminoquinolines; Asian People; Cells, Cultured; Chromosomes, Human, X; Female; Gene Expression Profiling; Genes, X-Linked; Genetic Variation; Genotype; Hepacivirus; Hepatitis C; Humans; Imiquimod; Interferon Inducers; Interferon-alpha; Interleukin-6; Linkage Disequilibrium; Male; Middle Aged; Polymorphism, Single Nucleotide; Sex Factors; Toll-Like Receptor 7 | 2014 |
Sustained viral load reduction in treatment-naive HCV genotype 1 infected patients after therapeutic peptide vaccination.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aminoquinolines; Antiviral Agents; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Imiquimod; Immunotherapy; Injections, Intradermal; Injections, Subcutaneous; Male; Middle Aged; RNA, Viral; Treatment Outcome; Vaccines, Subunit; Viral Hepatitis Vaccines; Viral Load; Young Adult | 2012 |
Synthesis and evaluation of 2-substituted 8-hydroxyadenines as potent interferon inducers with improved oral bioavailabilities.
Topics: Adenine; Administration, Oral; Aminoquinolines; Animals; Biological Availability; Cells, Cultured; Dose-Response Relationship, Drug; Hepatitis C; Imiquimod; Interferons; Mice; Rats; Structure-Activity Relationship | 2004 |